Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, andToxoplasma gondiichallenges with a single dose
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, andToxoplasma gondiichallenges with a single dose
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 29, Pages E4133-E4142
Publisher
Proceedings of the National Academy of Sciences
Online
2016-07-06
DOI
10.1073/pnas.1600299113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature
- (2015) Omar F. Khan et al. NANO LETTERS
- Alphaviruses in Gene Therapy
- (2015) Kenneth Lundstrom Viruses-Basel
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
- (2015) Jonathan D. Fuchs et al. Open Forum Infectious Diseases
- Ionizable Amphiphilic Dendrimer-Based Nanomaterials with Alkyl-Chain-Substituted Amines for Tunable siRNA Delivery to the Liver Endothelium In Vivo
- (2014) Omar F. Khan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Transcriptome-wide Mapping Reveals Widespread Dynamic-Regulated Pseudouridylation of ncRNA and mRNA
- (2014) Schraga Schwartz et al. CELL
- The ReNAissanCe of mRNA-based cancer therapy
- (2014) Sandra Van Lint et al. Expert Review of Vaccines
- Self-replicating alphavirus RNA vaccines
- (2014) Karl Ljungberg et al. Expert Review of Vaccines
- Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors
- (2014) Estrella Lopez-Gordo et al. HUMAN GENE THERAPY
- Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant
- (2014) Mark J. Mulligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
- (2014) W. M. Bogers et al. JOURNAL OF INFECTIOUS DISEASES
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
- (2014) Luis A Brito et al. MOLECULAR THERAPY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation
- (2014) Karen A. O. Martins et al. PLoS One
- Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9
- (2014) Saima M. Sidik et al. PLoS One
- Vaccines, new opportunities for a new society
- (2014) R. Rappuoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
- (2014) Julia Scheiermann et al. VACCINE
- Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
- (2014) Kathryn A. Whitehead et al. Nature Communications
- Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
- (2014) Kyle K. L. Phua et al. Scientific Reports
- Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae
- (2013) Jens H. Kuhn et al. ARCHIVES OF VIROLOGY
- Bioengineering virus-like particles as vaccines
- (2013) Linda H.L. Lua et al. BIOTECHNOLOGY AND BIOENGINEERING
- Vaccines againstToxoplasma gondii: new developments and perspectives
- (2013) Nian-Zhang Zhang et al. Expert Review of Vaccines
- RNA Replicon Delivery via Lipid-Complexed PRINT Protein Particles
- (2013) Jing Xu et al. MOLECULAR PHARMACEUTICS
- RNA-Based Vaccination: Sending a Strong Message
- (2013) David B. Weiner MOLECULAR THERAPY
- Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus
- (2013) Stephanie K. Dougan et al. NATURE
- A review on current downstream bio-processing technology of vaccine products
- (2013) Michael Li et al. VACCINE
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research
- (2013) Elena Mata et al. Biomed Research International
- Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
- (2013) Armin Hekele et al. Emerging Microbes & Infections
- Lipid nanoparticle delivery systems for siRNA-based therapeutics
- (2013) C. Wan et al. Drug Delivery and Translational Research
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Annual Cost of Illness and Quality-Adjusted Life Year Losses in the United States Due to 14 Foodborne Pathogens
- (2012) SANDRA HOFFMANN et al. JOURNAL OF FOOD PROTECTION
- Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
- (2012) Katalin Karikó et al. MOLECULAR THERAPY
- Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
- (2012) Charlotte Pollard et al. MOLECULAR THERAPY
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
- (2012) M. L. Bagarazzi et al. Science Translational Medicine
- RNA-based vaccines
- (2012) Jeffrey B. Ulmer et al. VACCINE
- Clinical Applications of DNA Vaccines: Current Progress
- (2011) B. Ferraro et al. CLINICAL INFECTIOUS DISEASES
- Tumor vaccination using messenger RNA: prospects of a future therapy
- (2011) Sebastian Kreiter et al. CURRENT OPINION IN IMMUNOLOGY
- Trends in vaccine adjuvants
- (2011) Virgil EJC Schijns et al. Expert Review of Vaccines
- IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use
- (2011) Paola Rizza et al. Expert Review of Vaccines
- Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial
- (2011) Beryl A. Koblin et al. PLoS One
- Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
- (2011) Rebecca J. Cox et al. VACCINE
- Viruses—from pathogens to vaccine carriers
- (2011) Juliana C Small et al. Current Opinion in Virology
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research
- (2010) Luis A. Brito et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[N-(N′,N′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome Retention Mediates Stronger Th1 Responses
- (2010) Malou Henriksen-Lacey et al. MOLECULAR PHARMACEUTICS
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Rationalizing the development of live attenuated virus vaccines
- (2010) Adam S Lauring et al. NATURE BIOTECHNOLOGY
- The RNA modification database, RNAMDB: 2011 update
- (2010) W. A. Cantara et al. NUCLEIC ACIDS RESEARCH
- Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivo
- (2010) J. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009–2010 and comparison with previous estimates and global action plan targets
- (2010) Jeffrey Partridge et al. VACCINE
- Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial Cells
- (2009) Zhenjia Wang et al. ACS Nano
- Induction of type I interferon by RNA viruses: cellular receptors and their substrates
- (2009) Alina Baum et al. AMINO ACIDS
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken Eggs
- (2009) Z. Chen et al. JOURNAL OF VIROLOGY
- Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?
- (2009) Renato Sathler-Avelar et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
- (2009) Zuzana Biesova et al. VACCINE
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now